Streetbeat News

Stock Prices

ALLR

Allarity Therapeutics Inc (NASDAQ:ALLR) and Detsamma Investments Pty Ltd have entered a Clinical Collaboration Agreement. Under this agreement, Allarity will support FivepHusion's future clinical development of Deflexifol for solid tumors. FivepHusion will receive a first option to negotiate and obtain from Allarity a global, exclusive license to use and commercialize the DRP-5FU CDx through Phase 3 registration trials, regulatory approval, and market. Financial terms of the collaboration are not disclosed.

Portfolio Pulse from Vandana Singh

July 31, 2023 | 3:55 pm

GDRX

GoodRx Holdings, Inc. (GDRX) shares are trading higher after TD Cowen upgraded its rating of the stock to Outperform and raised its price target from $6.5 to $12. The company's shares are up more than 30% on heavy trading volume. GoodRx also announced the release of its Medicine Cabinet app for iOS and will report its Q2 financial results on Aug. 9.

Portfolio Pulse from Erica Kollmann

July 31, 2023 | 3:52 pm

SNMP

Trading of Evolve Transition Infrastructure LP Common Units (SNMP) was halted due to a circuit breaker after the stock surged by 130.8%.

Portfolio Pulse from Happy Mohamed

July 31, 2023 | 3:49 pm

ORCL

A large bullish position has been taken on Oracle (NYSE:ORCL), as noticed by Benzinga's options scanner. The sentiment among big-money traders is split between 53% bullish and 46% bearish. Whales have been targeting a price range from $105.0 to $130.0 for Oracle over the last 3 months. Piper Sandler has downgraded its action to Overweight with a price target of $130.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 3:45 pm

MA

A significant amount of unusual options activity has been observed for Mastercard (NYSE:MA), with a majority of investors taking a bullish stance. The trades indicate a targeted price range of $355 to $400 for Mastercard over the last 3 months. The current price of MA is up 0.73% at $395.82. Several financial institutions have maintained positive ratings on Mastercard, with price targets ranging from $430 to $488.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 3:45 pm

PBR

A significant bearish stance has been taken on Petrobras Brasileiro (NYSE:PBR) as indicated by unusual options activity. The sentiment among these big-money traders is split between 40% bullish and 60% bearish. The whales have been targeting a price range from $13.0 to $20.0 for Petrobras Brasileiro over the last 3 months. The current price of PBR is up 4.92% at $14.62. Bradesco Corretora maintains a Neutral rating on Petrobras Brasileiro with a price target of $10.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 3:45 pm

W

Piper Sandler analyst Peter Keith has upgraded Wayfair Inc (NYSE:W) from Neutral to Overweight and raised the price target from $35 to $97. Keith believes that Wayfair is on the verge of sustained EBITDA profitability, with the home furnishings industry stabilizing and Wayfair's sales improving. The company's Investor Day on August 10th is expected to provide investors with greater long-term confidence on profitability outlook.

Portfolio Pulse from Priya Nigam

July 31, 2023 | 3:43 pm

FFIN

First Financial Bankshares, Inc. (NASDAQ:FFIN) has announced the renewal of its existing stock repurchase plan. The company may repurchase up to 5 million shares of its common stock from July 25, 2023, through July 31, 2024. This represents approximately 3.5% of the company's outstanding shares. The repurchase will be made through the open market, block trades, or privately negotiated transactions.

Portfolio Pulse from Happy Mohamed

July 31, 2023 | 3:31 pm

BLK

BlackRock (NYSE:BLK) has outperformed the market over the past 20 years, producing an average annual return of 15.11%. If an investor had bought $100 of BLK stock 20 years ago, it would be worth $1,672.20 today.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 3:30 pm

LMT

Lockheed Martin Inc.'s (NYSE:LMT) shares are currently trading at $446.56, after a 0.54% decrease. Over the past month, the stock decreased by 3.50%, but over the past year, it spiked by 4.14%. The company's P/E ratio is 16.46, lower than the Aerospace & Defense industry average of 36.28, indicating that the stock might be undervalued or expected to perform worse than its industry peers.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 3:30 pm